| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
lncRNA radiation induced regulator of PLK1 and RAD51 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||||
|
IQ motif and Sec7 domain ArfGEF 3 | 3.9E-03 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2019 | 2019 | ||||||||||
|
prenylcysteine oxidase 1 | 2.2E-15 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
nuclear RNA export factor 4 pseudogene |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 2015 | 2015 | |||||||||||
|
RFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase | 3.8E-09 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
rabenosyn, RAB effector | 1.000 | 2.3E-02 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
phosphorylase kinase catalytic subunit gamma 1 pseudogene 2 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
group | 0.310 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
small nucleolar RNA, C/D box 50B |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2016 | 2016 | |||||||||||
|
golgin A6 family like 7 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||||
|
fatty acid amide hydrolase pseudogene 1 |
|
phenotype | 0.300 | limited | 1.000 | 1 | 0 | 2019 | 2019 | |||||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
zona pellucida glycoprotein 2 | 0.931 | 6.2E-08 |
|
disease | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | |||||||||
|
trafficking protein particle complex 6A | 0.931 | 5.1E-08 |
|
disease | 0.310 | limited | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
trafficking protein particle complex 6A | 0.931 | 5.1E-08 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 2018 | 2018 | |||||||||
|
MAP7 domain containing 3 | 4.6E-10 |
|
group | 0.300 | limited | 1.000 | 1 | 0 | 1989 | 1989 | ||||||||||
|
podocan like 1 | 4.4E-13 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2017 | 2017 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
pleckstrin homology domain containing S1 | 2.1E-22 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2014 | 2014 | ||||||||||
|
haloacid dehalogenase like hydrolase domain containing 2 | 3.9E-06 |
|
phenotype | 0.300 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||||
|
MON1 homolog A, secretory trafficking associated | 2.3E-09 |
|
group | 0.300 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||||
|
keratin 87 pseudogene |
|
phenotype | 0.300 | strong | 1.000 | 1 | 0 | 2015 | 2015 |